Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update

Novocure (NVCR) Tops Q2 EPS by 6c, Revenues Beat

July 25, 2019 6:16 AM EDT

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $86.7 million versus the consensus estimate of $80.24 million.

Quarterly net revenues of $86.7 million, representing 41 percent growth versus the second quarter 2018The NovoTTF-100L System FDA approved to treat malignant pleural mesothelioma in combination with standard chemotherapies, Novocures first FDA-approved torso... More